Literature DB >> 26184985

Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions.

Jennifer E Fugate1, Alejandro A Rabinstein2.   

Abstract

Almost two decades have elapsed since posterior reversible encephalopathy syndrome (PRES) was described in an influential case series. This usually reversible clinical syndrome is becoming increasingly recognised, in large part because of improved and more readily available brain imaging. Although the pathophysiological changes underlying PRES are not fully understood, endothelial dysfunction is a key factor. A diagnosis of PRES should be considered in the setting of acute neurological symptoms in patients with renal failure, blood pressure fluctuations, use of cytotoxic drugs, autoimmune disorders, or eclampsia. Characteristic radiographic findings include bilateral regions of subcortical vasogenic oedema that resolve within days or weeks. The presence of haemorrhage, restricted diffusion, contrast enhancement, and vasoconstriction are all compatible with a diagnosis. In most cases, PRES resolves spontaneously and patients show both clinical and radiological improvements. The range of symptoms that can comprise the syndrome might be broader than usually thought. In its mild form, this disorder might cause only one clinical symptom (headache or seizure) and radiographically might show few areas of vasogenic oedema or even normal brain imaging in some rare cases. In severe forms, PRES might cause substantial morbidity and even mortality, most often as a result of acute haemorrhage or massive posterior fossa oedema causing obstructive hydrocephalus or brainstem compression.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26184985     DOI: 10.1016/S1474-4422(15)00111-8

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  192 in total

1.  Posterior reversible encephalopathy syndrome coexists with acute cerebral infarction: challenges of blood pressure management.

Authors:  Luji Liu; Lihong Zhang
Journal:  Quant Imaging Med Surg       Date:  2020-12

Review 2.  Maternal Stroke: an Update.

Authors:  Maria D Zambrano; Eliza C Miller
Journal:  Curr Atheroscler Rep       Date:  2019-06-22       Impact factor: 5.113

3.  Posterior reversible encephalopathy syndrome in pregnancy: a retrospective series of 36 patients from mainland China.

Authors:  Y Wen; B Yang; Q Huang; Y Liu
Journal:  Ir J Med Sci       Date:  2017-02-02       Impact factor: 1.568

4.  A study on clinical characteristics and the causes of missed diagnosis of reversible posterior leukoencephalopathy syndrome in eclampsia.

Authors:  Tong Shen; Hao Chen; Jia Jing; Hafiz Khuram Raza; Zuozhui Zhang; Lei Bao; Su Zhou; Shenyang Zhang; Guiyun Cui
Journal:  Neurol Sci       Date:  2019-05-07       Impact factor: 3.307

Review 5.  [Infections of the central nervous system by protozoa, helminths and fungi].

Authors:  Nikolaus Deigendesch; Dirk Schlüter; Eberhard Siebert; Werner Stenzel
Journal:  Nervenarzt       Date:  2019-06       Impact factor: 1.214

6.  Central-variant posterior reversible encephalopathy syndrome with bilateral corticospinal tract involvement: a case report.

Authors:  Ning Han; Zhanyong Sun; Chenguang Zhou; Yaoyao Shen; Guanqing Li; Jianhua Wang
Journal:  Acta Neurol Belg       Date:  2020-07-15       Impact factor: 2.396

7.  Posterior reversible encephalopathy syndrome with colitis in a patient treated with panitumumab.

Authors:  Céline Blaye; Xavier Buy; Marine Gross-Goupil; Didier Vincent; Claire Jamet; Paul Sargos; Stéphane Culine; Guilhem Roubaud
Journal:  Ther Adv Drug Saf       Date:  2017-01-16

Review 8.  Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.

Authors:  Melinda Liu; Yuan Yu M Huang; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

Review 9.  Posterior reversible encephalopathy syndrome in Henoch-Schönlein purpura.

Authors:  Sebastiano A G Lava; Gabriëlla G A M Peeters; Mario G Bianchetti; Barbara Goeggel Simonetti; Giacomo D Simonetti; Gregorio P Milani
Journal:  Rheumatol Int       Date:  2016-10-21       Impact factor: 2.631

10.  Pressing Issues in COVID-19: Probable Cause to Seize SARS-CoV-2 for Its Preferential Involvement of Posterior Circulation Manifesting as Severe Posterior Reversible Encephalopathy Syndrome and Posterior Strokes.

Authors:  F D'Amore; G Vinacci; E Agosti; L P Cariddi; A V Terrana; F A Vizzari; M Mauri; A Giorgianni
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-30       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.